Journal
Clinical cardiology
Publication Date
7-1-2020
Volume
43
Issue
7
First Page
743
Last Page
751
Document Type
Open Access Publication
DOI
10.1002/clc.23376
Rights and Permissions
Sciria, CT, Maddox, TM, Marzec, L, et al. Switching warfarin to direct oral anticoagulants in atrial fibrillation: Insights from the NCDR PINNACLE registry. Clin Cardiol. 2020; 43: 743– 751. https://doi.org/10.1002/clc.23376 © 2020 The Authors. Clinical Cardiology published by Wiley Periodicals, Inc. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
Recommended Citation
Sciria, Christopher T; Maddox, Thomas M; and et al, "Switching warfarin to direct oral anticoagulants in atrial fibrillation: Insights from the NCDR PINNACLE registry." Clinical cardiology. 43, 7. 743 - 751. (2020).
https://digitalcommons.wustl.edu/open_access_pubs/10044
Figure S1 Switching from Warfarin to DOAC Stratified by CHA2DS2‐VASc Score Tertiles
clc23376-sup-0002-figures2.pdf (68 kB)
Figure S2 Univariate Hierarchical Regression Model with CHA2DS2‐VASc Score Only
clc23376-sup-0003-figures3.pdf (167 kB)
Figure S3 Predictors of Switching from Warfarin to DOACs (with Covariates of the CHA2DS2‐VASc Score)
clc23376-sup-0004-figures4.pdf (127 kB)
Figure S4 Multiple Anticoagulation Switches Flow Chart
clc23376-sup-0005-tables1.pdf (97 kB)
Table S1 Patient Characteristics, Entire Population Initially Managed on Warfarin
clc23376-sup-0006-tables2.pdf (120 kB)
Table S2 Patient Characteristics ‐ Switched to DOAC vs Not Switched
clc23376-sup-0007-tables3.pdf (146 kB)
Table S3 Patients Characteristics ‐ by Switching Cohorts
clc23376-sup-0008-tables4.pdf (63 kB)
Table S4 Practice Characteristics ‐ All Analysis Population
clc23376-sup-0009-tables5.pdf (55 kB)
Table S5 Switching from Warfarin to DOAC by Time Period
clc23376-sup-0010-tables6.pdf (53 kB)
Table S6 Time from Initial Visit to First Switch
